Skip to main content
. 2020 Aug 10;2(5):589–599.e1. doi: 10.1016/j.xkme.2020.06.008

Table 1.

Patient Demographics

Overall Cohort: Hyporesponder (N = 43,316) Overall Cohort: Normoresponder (N = 67,403) P
Demographics on index date
 Age as of index date, y 62.3 ± 15.2 63.6 ± 14.4 <0.001a
 Female 24,272 (56.0) 33,194 (49.2) <0.001a
 Race <0.001a
 Black 17,979 (41.5) 25,022 (37.1)
 White 22,225 (51.3) 38,242 (56.7)
 Other/unknown 3,112 (7.2) 4,139 (6.1)
 Weight on index date, kg 73.0 ± 20.2 83.4 ± 23.9 <0.001a
Comorbid conditions during baseline period
 Charlson Comorbidity Index score 3.8 ± 2.2 3.2 ± 2.0 <0.001a
 Hypertension 38,151 (88.1) 54,544 (80.9) <0.001a
 Type 2 diabetes 22,462 (51.9) 36,277 (53.8) <0.001a
 Hyperlipidemia 22,092 (51.0) 32,365 (48.0) <0.001a
 Heart failure 20,777 (48.0) 24,412 (36.2) <0.001a
 Coronary heart/artery disease 18,071 (41.7) 23,643 (35.1) <0.001a
 Arrhythmia 14,121 (32.6) 17,064 (25.3) <0.001a
 Type 1 diabetes 5,124 (11.8) 7,855 (11.7) 0.38
 Valvular heart disease 1,305 (3.0) 1,200 (1.8) <0.001a
Cardiovascular event–related hospitalizations during baseline period
 Hospitalization related to heart failure 2,308 (5.3) 1,931 (2.9) <0.001a
 Hospitalization related to thromboembolic event 396 (0.9) 219 (0.3) <0.001a
 Hospitalization related to stroke 232 (0.5) 205 (0.3) <0.001a
 Hospitalization related to myocardial infarction 318 (0.7) 270 (0.4) <0.001a

Note: Data for categorical variables expressed as number (percent); data for continuous variables expressed as mean ± standard deviation.

a

Statistically significant.